Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Kimberly-Clark (KMB): An Overlooked Dividend King Income Investors Should Know

Kimberly-Clark Corporation (NASDAQ:KMB) is not usually the first name that comes up when investors discuss Dividend Kings. Its track record says it probably should be. The consumer staples company has increased its dividend for 54 consecutive years and has paid dividends for 92 years. For income investors, that kind of consistency is difficult to dismiss.

In January 2026, Kimberly-Clark raised its quarterly dividend from $1.26 to $1.28 per share, taking the annual payout to $5.12 per share. With the stock trading near $110, that works out to a yield of about 4.6%. The yield stands out even more when paired with a dividend that has been growing for more than five decades.

Image by Steve Buissinne from Pixabay

A Dividend Supported by Essential Products

Much of Kimberly-Clark Corporation (NASDAQ:KMB)’s appeal comes from what it sells. Its products are not things people buy only when the economy is doing well. Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise and Depend are familiar names, and the company says its brands hold No. 1 or No. 2 positions in roughly 70 countries.

That gives the company a fairly dependable source of demand. When money gets tight, consumers may postpone larger or less essential purchases, but diapers, tissues, toilet paper, and personal-care products still have to be bought. This helps Kimberly-Clark keep its revenue and cash flow steadier than companies that rely more heavily on discretionary spending.

The downside is that the dividend is not growing very quickly. Its five-year annualized growth rate is around 3%, which means investors are unlikely to see large increases each year. Still, the company has continued to raise the payout through inflation, weaker consumer spending, and periods of margin pressure. For some income investors, that reliability matters more than fast dividend growth.

Cash Flow Is the Key

The 54-year streak is impressive, but a long history alone does not pay the dividend. Kimberly-Clark Corporation (NASDAQ:KMB) also needs to keep producing enough cash to fund the payout and invest in the business at the same time.

The numbers from the first half of 2026 were encouraging. Cash from operations, including discontinued operations, came in at $1.7 billion, up from $1.1 billion a year earlier. Capital spending also increased, reaching $776 million versus $401 million previously. At the same time, Kimberly-Clark paid $843 million in dividends to shareholders.

Management is expecting about $2 billion in adjusted free cash flow for 2026, which would be roughly in line with 2025. That is despite plans to spend about $1.3 billion on capital investments. That is important because the dividend ultimately depends on cash generation. With solid free cash flow, Kimberly-Clark Corporation (NASDAQ:KMB) can continue paying shareholders while putting money into the business and managing its balance sheet.

The Kenvue Deal Could Change the Growth Story

The Kenvue acquisition could be where the story gets more interesting. The deal would expand Kimberly-Clark Corporation (NASDAQ:KMB)’s presence in health and wellness and give it a larger portfolio of products to work with. More importantly, it could provide a new source of growth at a company where dividend growth has been fairly modest.

Management expects the transaction to add about $1.9 billion in cost synergies and another $500 million in profit from revenue synergies within three to four years of closing. If those targets are achieved, the deal could make a meaningful difference to Kimberly-Clark’s earnings. Getting there, though, will take time and investment.

The deal is not without its risks. Kenvue has been dealing with inflation, tariffs, and currency headwinds, and Kimberly-Clark will have to absorb a large acquisition. The transaction is expected to close in the fourth quarter of 2026, which means investors will not see the full benefits right away. Execution will matter a lot.

If the integration goes well, Kimberly-Clark Corporation (NASDAQ:KMB) could come out of the deal with a broader health and personal-care business and better growth prospects. Higher earnings and stronger cash flow would also give the company more flexibility when it comes to future dividend increases.

The Bottom Line

Kimberly-Clark’s dividend record has never been about spectacular growth. The company has built it the slower way: selling everyday products, generating cash and steadily returning part of that cash to shareholders through different economic cycles.

The roughly 4.6% yield is a big part of the investment case. The dividend is growing slowly, so investors should keep their expectations in check on future increases. But starting with a higher yield can make even modest raises worthwhile for someone whose main goal is income.

Kenvue makes the outlook less straightforward, but it also gives Kimberly-Clark Corporation (NASDAQ:KMB) an opportunity to change its growth trajectory. There will be financial and execution risks during the integration. If management gets the deal right, stronger earnings and cash flow could eventually give shareholders more upside.

For investors who put dependable income ahead of rapid growth, Kimberly-Clark remains worth considering. The dividend may only be growing at a modest pace, but the 54-year streak, everyday product portfolio, and cash generation give the stock a solid foundation. Kenvue raises the level of risk, but it could also be the change Kimberly-Clark needs to improve growth. If management delivers on its synergy targets and turns the acquisition into stronger cash flow, the stock could become more attractive to long-term income investors.

While we acknowledge the risk and potential of KMB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than KMB and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Medtronic plc (MDT) is Closing in on Dividend King Status and PepsiCo (PEP)’s Dividend is Strong but the Stock Needs a Turnaround

Disclosure: None. This article is originally published at Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.